Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

Año publicación: 2024

Subir documento: https://drive.google.com/file/d/19oI1BEWoDyey9DlcxT8r6PWQ6gUtTl3V/view?usp=sharing

Nombre investigadores: Richard M Bergenstal, Ruth S Weinstock, Chantal Mathieu, Yukiko Onishi, Vishali Vijayanagaram, Michelle L Katz, Molly C Carr, Annette M Chang